MINIMAL CHANGE DISEASE FOLLOWING THE SECOND DOSE OF PFIZER-BIONTECH (BNT162B1) FOR SARS-COV-2. COINCIDENCE OR CAUSALITY?

Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/607cb9e5e2e204c769c87c8b63737409.pdf

Abstract Title

MINIMAL CHANGE DISEASE FOLLOWING THE SECOND DOSE OF PFIZER-BIONTECH (BNT162B1) FOR SARS-COV-2. COINCIDENCE OR CAUSALITY?

First Name *

Juan Carlos

Last Name *

González García

Co-author 1

David Medina Julio dmj25dmj@gmail.com Hospital General Dr. Manuel Gea González Internal Medicine Ciudad de México

Co-author 2

Joana Balderas Juárez jobaju1@hotmail.com Hospital General Dr. Manuel Gea González Nephrology Ciudad de México

Co-author 3

Mauricio Adrián Salinas Ramírez salinasmau89@gmail.com Hospital General Dr. Manuel Gea González Nephrology Ciudad de México

Co-author 4

Erika Karina Tenorio Aguirre karitenorio03@gmail.com Hospital General Dr. Manuel Gea González Internal Medicine Ciudad de México

Co-author 5

María Virgilia Soto Abraham virgiliasoto@gmail.com Hospital de Cardiología Ignacio Chávez Nephropatology Ciudad de México

Co-author 6

Co-author 7

Co-author 8

Co-author 9

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15